Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-02-04 01:20 | 2017-02-02 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | OPT+S | $77.14 | 11,162 | $861,085 | 38,292 | -22.6% |
| 2016-02-03 22:02 | 2016-02-01 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | OPT+S | $77.78 | 10,483 | $815,346 | 36,931 | -22.1% |
| 2015-02-06 18:00 | 2015-02-04 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | SALE | $70.00 | 5,316 | $372,120 | 55,061 | -8.8% |
| 2015-02-04 00:06 | 2015-02-02 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | OPT+S | $71.84 | 10,068 | $723,285 | 60,377 | -14.3% |
| 2014-02-04 23:48 | 2014-02-03 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | SALE | $0.00 | 16,562 | $0 | 58,990 | -21.9% |
| 2013-02-07 17:29 | 2013-02-05 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | SALE | $54.21 | 29,646 | $1,607,110 | 52,605 | -36.0% |
| 2012-02-02 23:39 | 2012-02-01 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | OPT+S | $39.81 | 21,384 | $851,241 | 56,196 | -27.6% |
| 2011-02-18 00:31 | 2011-02-15 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | SALE | $34.55 | 12,441 | $429,837 | 39,461 | -24.0% |
| 2010-02-05 00:48 | 2010-02-03 | LLY | ELI LILLY & Co | Rice Derica W | Officer; EVP-Global Services and CFO | Pharmaceutical Preparations | SALE | $35.23 | 8,200 | $288,880 | 18,843 | -30.3% |
| 2006-08-23 22:03 | 2006-08-21 | LLY | ELI LILLY & Co | Rice Derica W | Officer; Sr. Vice President and CFO | Pharmaceutical Preparations | OPT+S | $55.03 | 1,400 | $77,042 | 12,410 | -10.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.